Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Drive Innovation

How patient-centered pioneers are blurring industry lines

Overheard at the J.P. Morgan Healthcare Conference

Executives detailed plans to take on more risk, build on advances in life sciences, and expressed optimism in Medicare Advantage, despite missing enrollment targets.

Despite the pandemic maintaining its grip on the economy, 2022 will be another hot year for healthcare.

Global Leader, Health and Life Sciences, Oliver Wyman

An inside look at Healthworx’s strategies to execute fast innovation, versus failed innovation.

Head of Healthworx and Senior Vice President, Corporate Development, CareFirst BlueCross BlueShield
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

During the Health Innovation Summit Closing Capstone, speakers from Intermountain, Northwestern, and Oak HC/FT talked about the need for leaders to take risks and be willing to learn from missteps.

Five tech-driven companies share how to create a more consumer-centric model

Innovative technologies aim to upend the status quo by giving consumers more control over their care journey.

Insights in your inbox

Subscribe

Life sciences companies need to be more engaged in building partnerships that promote high-value care.

Global Leader, Health and Life Sciences, Oliver Wyman
Life Sciences Business Leader, Huron

Incremental change can no longer be the norm in the industry, confirmed speakers at the 2021 Oliver Wyman Health Innovation Summit.

A conversation around what the future holds for AI, the insurer mix shift, and more. 

Founder and CEO, Softheon
Partner, Health and Life Sciences, Oliver Wyman

In this podcast, we discuss how leaders can practice operational resilience as cybersecurity threats in healthcare become more prevalent.

Partner, Digital and Financial Services, Cyber Platform Lead, Oliver Wyman
Co-founder and CEO, QOMPLX

It's time to address the billion dollar telehealth question.

CEO, American Well
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe